Short article about the difference between the COVID-19 antiviral pills made by Merck and Pfizer mentions ISMP’s January 3, 2022, alert that patients with severe renal impairment should not receive the drug, while those with moderate renal impairment should receive a dose reduction.
For the full text, visit Becker’s Hospital Review online.
